Camurus AB (publ)
Status: Publicly traded
Direct answer
Camurus AB (publ) is publicly traded on LSE under the ticker 0RD1.L.
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat...
Can you invest in Camurus AB (publ)?
Yes. Camurus AB (publ) trades publicly on LSE as 0RD1.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Camurus AB (publ)
Detailed equity research is provided by MarketSnap.